AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitazox-M Tablet

Prescription Icon
Prescription Required

Marketer

Howay Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitazox-M Tablet

Diabex Duo tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo may be used independently or with other diabetes treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your doctor's guidance. Maintaining your prescribed diet and exercise plan is crucial for diabetes control; lifestyle choices significantly impact management. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a possibility, especially when used with insulin or sulfonylureas; learn to identify and manage this. This medication isn't suitable for all individuals. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before use. Pregnant or breastfeeding women need medical consultation prior to use. Other medications may interact with Diabex Duo; fully disclose all current medications to ensure safety. Alcohol consumption should be minimized due to its blood sugar-lowering effect. Your doctor will monitor your kidney function and glucose levels throughout treatment.

Primary Ingredients of Sitazox-M Tablet

No text provided to rephrase.

Uses of Sitazox-M Tablet

Managing type 2 diabetes

Major Benefits of Sitazox-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitazox-M Tablet with a meal.

Common Side effects of Sitazox-M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitazox-M Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitazox-M Tablet with a meal.

How Sitazox-M Tablet works:

Sitagliptin and metformin, the components of Sitazox-M Tablet, work synergistically to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This combined action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Sitazox-M Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitazox-M Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitazox-M tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitazox-M tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitazox-M tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should not take Sitazox-M Tablets; this medication poses a likely risk. Medical advice is recommended.

What if you forget to take Sitazox-M Tablet :

Should you forget a Sitazox-M Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitazox-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitazox-M Tablet

Sitazox-M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitazox-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitazox-M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Sitazox-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazox-M tablets and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (Sitazox-M Tablet) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitazox-M and seek immediate medical attention.
Sitazox-M tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitazox-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitazox-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazox-M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitazox-M (containing metformin) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect necessitates avoiding Sitazox-M in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitazox-M and seek immediate medical attention.
Prolonged Sitazox-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitazox-M Tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitazox-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitazox-M Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazox-M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitazox-M (containing metformin) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitazox-M and seek immediate medical attention.
Prolonged Sitazox-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitazox-M Tablet
140